Hong‐Jen Liang

436 citations
14 papers · 382 indexed · h-index 11
Topics
Blood properties and coagulation (2 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers)Chemotherapy-induced organ toxicity mitigation (1 paper)
Partner nations
TaiwanUnited Kingdom

In The Last Decade

Hong‐Jen Liang

13 papers receiving 370 citations

Peers

Hong‐Jen Liang
Comparison fields: 5 of 94
  • Molecular Biology 109
  • Immunology 83
  • Pharmacology 64
  • Plant Science 55
  • Materials Chemistry 47
Replace Hongmei Niu with:
Hongmei Niu China
Qingwei Wang China
Kun Park South Korea
Giovanni K. Zorzi Brazil
Saravut Satitsri Thailand
Tongbo Zhu China
Young Geol Yoon South Korea
Tomonori Suzuki Japan
Puze Li China
Zhongchao Gai China
Hong‐Jen Liang relative to Hongmei Niu China Hongmei Niu's profile →
Citations per field
00.5×3.4×
Hongmei Niu · 1×
Citations per year

Countries citing papers authored by Hong‐Jen Liang

Since Specialization
Citations

This map shows the geographic impact of Hong‐Jen Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Jen Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Jen Liang more than expected).

Fields of papers citing papers by Hong‐Jen Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Jen Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Jen Liang. The network helps show where Hong‐Jen Liang may publish in the future.

Co-authorship network of co-authors of Hong‐Jen Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Jen Liang. A scholar is included among the top collaborators of Hong‐Jen Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Jen Liang. Hong‐Jen Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 2
2 0
3 29
4 3
5 55
6 68
7 10
8 12
9 82
10 33
11 12
12 36
13 14
14 26

About Hong‐Jen Liang

Hong‐Jen Liang is a scholar working on Microbiology, Complementary and alternative medicine and Physiology, having authored 14 papers that have together received 382 indexed citations. Recurring topics across this work include Blood properties and coagulation (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Chemotherapy-induced organ toxicity mitigation (1 paper). The work is most often cited by research in Endocrinology (24 citations), Immunology (83 citations) and Pharmacology (64 citations). Hong‐Jen Liang has collaborated with scholars based in Taiwan and United Kingdom. Frequent co-authors include Wen‐Chi Hou, Brent S. Murray, Chia‐Chi Wang, Tong‐Rong Jan, Hsin‐Ying Wu, Chung‐Hsiung Huang, Tzong‐Huei Lee, Ching‐Chiung Wang, Shyr‐Yi Lin and Pei‐Chi Wang. Their work appears in journals such as Langmuir, Journal of Agricultural and Food Chemistry and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026